Form 4: Teladoc Health Executive Mala Murthy Acquires 37,957 Restricted Stock Units
SEC Form 4 Filing
Mala Murthy, Acting CEO and CFO of Teladoc Health, acquired 37,957 restricted stock units on April 5, 2024, according to a Form 4 filing with the SEC.
Summary
- On April 5, 2024, Mala Murthy, the Acting CEO and CFO of Teladoc Health, acquired 37,957 restricted stock units (RSUs).
- These RSUs represent a contingent right to receive one share of Teladoc Health common stock per unit.
- The vesting schedule for these RSUs is as follows: one-third vests on the first anniversary of the grant date, and the remaining units vest in eight substantially equal quarterly installments starting June 1, 2025.
- The transaction was reported in a Form 4 filing with the Securities and Exchange Commission.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into the holdings of company insiders.
Stakeholder Impact
- The acquisition of restricted stock units by a key executive could be viewed positively by shareholders as it aligns the executive's interests with the company's long-term performance.
Key Dates
| Date | Description |
|---|---|
| 04/05/2024 | Date of transaction: Mala Murthy acquired 37,957 restricted stock units. |
| 06/01/2025 | Start date for the remaining RSUs vesting in eight substantially equal quarterly installments. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.